The National Primary Health Care Development Agency (NPHCDA) has stated there is no plan to discontinue the use of Oxford AstraZeneca vaccine.

The agency, in a statement on Saturday, affirmed Nigeria is continuing the process of administering roughly 4 million doses of the Oxford/AstraZeneca vaccine beginning with frontline health workers and vulnerable individuals.

It said: “There has been no change to current plans or supply.

“A huge number of countries around the world are administering the Oxford/AstraZeneca vaccine, including much of Europe, and the United Kingdom which has administered the most doses of AstraZeneca globally.

“The World Health Organisation, British and European health regulators all continue to advocate for the use of AstraZeneca.

“AstraZeneca’s strong effectiveness against COVID-19 has been demonstrated in clinical and human trials: it has been shown to be 76% effective at preventing COVID-19 and 100% effective at preventing severe disease and hospitalisation.

"Exciting news! TheNigeriaLawyer is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest legal insights!" Click here! ....................................................................................................................... Unauthorized use and/or duplication of this material and other digital content on this website, in whole or in part, without express and written permission from TheNigeriaLawyer, is strictly prohibited _________________________________________________________________

 To Register visit https://schoolofadr.com/how-to-enroll/ You can also reach us via email: info@schoolofadr.com or call +234 8053834850 or +234 8034343955. _________________________________________________________________

NIALS' Compendia Series: Your One-Stop Solution For Navigating Nigerian Laws (2004-2023)

Email: info@nials.edu.ng, tugomak@yahoo.co.uk, Contact: For Inquiry and information, kindly contact, NIALS Director of Marketing: +2348074128732, +2348100363602.